Details for New Drug Application (NDA): 209406
✉ Email this page to a colleague
NDA 209406 describes BRINZOLAMIDE, which is a drug marketed by Bausch And Lomb, Padagis Us, and Watson Labs Inc, and is included in three NDAs. It is available from five suppliers. Additional details are available on the BRINZOLAMIDE profile page.
The generic ingredient in BRINZOLAMIDE is brinzolamide. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the brinzolamide profile page.
The generic ingredient in BRINZOLAMIDE is brinzolamide. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the brinzolamide profile page.
Summary for 209406
| Tradename: | BRINZOLAMIDE |
| Applicant: | Watson Labs Inc |
| Ingredient: | brinzolamide |
| Patents: | 0 |
Pharmacology for NDA: 209406
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
Suppliers and Packaging for NDA: 209406
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BRINZOLAMIDE | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 209406 | ANDA | Actavis Pharma, Inc. | 0591-2127 | 0591-2127-12 | 1 BOTTLE, PLASTIC in 1 CARTON (0591-2127-12) / 15 mL in 1 BOTTLE, PLASTIC |
| BRINZOLAMIDE | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 209406 | ANDA | Actavis Pharma, Inc. | 0591-2127 | 0591-2127-79 | 1 BOTTLE, PLASTIC in 1 CARTON (0591-2127-79) / 10 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Nov 27, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
